H. Jantzem

Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer.

G. Quéré, R. Descourt, G. Robinet, 2019, European journal of cancer.

[Sorafenib-induced multiple eruptive keratoacanthomas].

J. Merrer, P. Spindler, H. Jantzem, 2009, Annales de dermatologie et de venereologie.

A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome

E. Lippert, J. Amiral, J. Ianotto, 2019, European Journal of Haematology.

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey

A. Bénard-Laribière, T. Vial, N. Bernard, 2015, BJOG : an international journal of obstetrics and gynaecology.

Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.

C. Lebbé, O. Lambotte, S. Ammari, 2022, European journal of cancer.

Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population.

G. Durrieu, F. Bellet, J. Béné, 2019, Therapie.

Complicated atazanavir-associated cholelithiasis: a report of 14 cases.

P. Tattevin, C. Arvieux, E. Polard, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hospital databases for the identification of adverse drug reactions: A 2‐year multicentre study in 9 French general hospitals

E. Oger, É. Bellissant, E. Polard, 2020, British journal of clinical pharmacology.

[Peranesthesic Anaphylactic Shocks: Contribution of a Clinical Data Warehouse].

Boris Campillo-Gimenez, Marc Cuggia, Elisabeth Polard, 2015, Therapie.

Dress syndrome secondary to different combinations of targeted therapy (iBRAF + iMEK)

M. Etienne, M. Robert, H. Jantzem, 2020, European Journal of Dermatology.

[DRESS syndrome related to Hexaquine (quinine and thiamine)].

J. Leroy, B. Sassolas, M. Greco, 2006, Annales de dermatologie et de venereologie.